These adverse events included upper respiratory infection, pneumonia, skin tissue infections, diarrhea, nausea, headache, leukopenia, and alanine transaminase/aspartate transaminase (ALT/AST) rise. This evidence concerns the gene GPT and respiratory tract infectious disorder.